Prestige Consumer Healthcare Inc. Leases Disclosure
| March 31, | |||||||||||
| (In thousands) | 2025 | 2024 | |||||||||
| Finance lease cost: | |||||||||||
| Amortization of right-of-use assets | $ | 2,230 | $ | 2,658 | |||||||
| Interest on lease liabilities | 375 | 88 | |||||||||
| Operating lease cost | 7,332 | 6,564 | |||||||||
| Short term lease cost | 139 | 132 | |||||||||
| Variable lease cost | 55,399 | 61,069 | |||||||||
| Total net lease cost | $ | 65,475 | $ | 70,511 | |||||||
| (In thousands) | ||||||||||||||||||||
| Year Ending March 31, | Operating Leases | Financing Leases | Total | |||||||||||||||||
| 2026 | $ | 7,595 | $ | 3,875 | $ | 11,470 | ||||||||||||||
| 2027 | 7,239 | 3,875 | 11,114 | |||||||||||||||||
| 2028 | 6,837 | 3,875 | 10,712 | |||||||||||||||||
| 2029 | 5,556 | 3,869 | 9,425 | |||||||||||||||||
| 2030 | 5,169 | 3,366 | 8,535 | |||||||||||||||||
| Thereafter | 1,147 | 10,658 | 11,805 | |||||||||||||||||
| Total undiscounted lease payments | 33,543 | 29,518 | 63,061 | |||||||||||||||||
| Less amount of lease payments representing interest | (4,764) | (6,404) | (11,168) | |||||||||||||||||
| Total present value of lease payments | $ | 28,779 | $ | 23,114 | $ | 51,893 | ||||||||||||||
| March 31, 2025 | |||||||||||
| Weighted average remaining lease term (years) | |||||||||||
| Operating leases | 4.76 | ||||||||||
| Financing leases | 8.09 | ||||||||||
| Weighted average discount rate | |||||||||||
| Operating leases | 6.55 | % | |||||||||
| Financing leases | 6.33 | % | |||||||||
Want the next Prestige Consumer Healthcare Inc. leases disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Prestige Consumer Healthcare Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.